An Update on Primary Drug Therapies for Alzheimer Disease
Arch Neurol 54:1406-1409, Knopman,D.S.&Morris,J.C., 1997
Clinical Experience with Donepezil Hydrochloride:A Case Study Perspective
Advan Therapy 14:305-311, Geldmacher,D.S., 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
Imaging the Brain in Dementia:Expensive and Futile
AJNR 18:1847-1850, George,A.E.,et al, 1997
Complete Genomic Screen in Late-Onset Familial Alzheimer Disease, Evidence for a New Locus on Chromosome 12
JAMA 278:1237-1241, 12821997., Pericak-Vance,M.A.,et al, 1997
Risk Factors for Developing Multiple Sclerosis after Childhood Optic Neuritis
Neurol 49:11413-1418, Lucchinetti,C.F.,et al, 1997
A Placebo-Controlled, Double-Blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
JAMA 278:1327-1332, LeBars,P.L.,et al, 1997
Delirium and a Subclavian Abscess
Lancet 350:1294, Yamasaki,K.,et al, 1997
Persistent Vegetative State in Alzheimer Disease
Arch Neurol 54:1382-1384, Volicer,L.,et al, 1997
Status Epilepticus Amauroticus
Neurol 49:1467-1469, Sawchuk,K.S.L.J.,et al, 1997
Weight Loss in People with Alzheimer's Disease:A Prospective Population Based Analysis
BMJ 314:178-179, Cronin-Stubbs,D.,et al, 1997
Drug Treatment of Alzheimer's Disease, Raise Clinical and Ethical Problems
BMJ 314:693-694, Kelley,C.A.,et al, 1997
Acute Ischemic Strokes Improving During the First 48 Hours of Onset:Predictability, Outcome & Possible Mechanisms
Stroke 28:10-14, Toni,D.,et al, 1997
Atrial Fibrillation and Dementia in a Population-Based Study, The Rotterdam Study
Stroke 28:316-321, Ott,A.,et al, 1997
Exploring the Etiology of Alzheimer Disease Using Molecular Genetics
JAMA 277:825-831, Lendon,C.L.,et al, 1997
Herpes Simplex Virus Type 1 in Brain and Risk of Alzheimer's Disease
Lancet 349:241-244, Itzhaki,R.F.,et al, 1997
Response of the Pupil to Tropicamide is not a Reliable Test of Alzheimer Disease
Arch Neurol 54:155-159, FitzSimon,J.S.,et al, 1997
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
Telling Patients They Have Alzheimer's Disease
BMJ 314:321-322, 375-3761997., Rice,K.,et al, 1997
Hereditary Frontotemporal Dementia is Linked to Chromosome 17q21-q22:Genetic & Clinicopath Study of 3 Dutch Families
Ann Neurol 41:150-159, Heutnik,P.,et al, 1997
Collection and Normal Levels of the Amyloid Precursor Protein in Plasma
Ann Neurol 41:121-124, Whyte,S.,et al, 1997
Assessment of CSF Levels of Tau Protein in Mildly Demented Patients with Alzheimer's Disese
Neurol 48:632-635, Galasko,D.,et al, 1997
Diagnosis of Viral Infections of the Central Nervous System:Clinical Interpretation of PCR Results
Lancet 349:313-317, Jeffery,K.J.M.,et al, 1997
Successful Treatment of Persistent Migraine Aura with Divalproex Sodium
Neurol 48:261-262, Rothrock,J.F., 1997
Acute Bacterial Meningitis in Adults, A 20-Yr Overview
Arch Int Med 157:425-430, Sigurdardottir,B.,et al, 1997
Criteria for Alzheimer's Disease and the Nosology of Dementia with Lewy Bodies
Neurol 48:126-132, Hansen,L.A.&Samuel,W., 1997
Hemorrhagic Transformation in Acute Ischemic Stroke
Stroke 28:957-960, Larrue,V.,et al, 1997
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
Increased Risk of Mortality in Alzheimer's Disease Patients with Higher Education
Neurol 49:798-802, Geerlings,M.I.,et al, 1997
Pupil Dilation to Tropicamide is not Specific for Alzheimer Disease
Arch Neurol 54:841-844, Growdon,J.H.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Reliability of Wash Univ Road Test:A Performance-Based Assess for Drivers with Dementia of Alzheimer Type
Arch Neurol 54:707-712, Hunt,L.A.,et al, 1997
Midline Cerebral Morphometry Distinguishes Frontotemporal Dementia and Alzheimer's Disease
Neurol 48:978-985, Kaufer,D.I.,et al, 1997
Simulated Car Crashes and Crash Predictors in Drivers with Alzheimer Disease
Arch Neurol 54:545-551, Rizzo,M.,et al, 1997
The Family Caregiver's Role in Alzheimer's Disease
Neurol 48 (Suppl 6) :S25-S29997., Haley,W.E., 1997
Predictors of Time to Institutionalization of Patients with Alzheimer's Disease:The CERAD Experience, Part XVII
Neurol 48:1304-1309, Heyman,A.,et al, 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Olfactory Dysfunction in Parkinson's Disease
JNNP 62:436-446, Hawkes,C.H.,et al, 1997
CT Angiography in the Evaluation of Acute Stroke
AJNR 18:1011-1020, 10211997., Shrier,D.A.,et al, 1997
Potential of CT Angiography in Acute Ischemic Stroke
AJNR 18:1001-1010, Knauth,M.,et al, 1997
Measurement of Acetylcholinesterase by PET in the Brains of Healthy Controls & Pts with Alzheimer's Disease
Lancet 349:1805-1809, Iyo,M.,et al, 1997
Enlargement of Human Cerebral Ischemic Lesion Volumes Measured by Diffusion-Weighted MRI
Ann Neurol 41:581-589, Baird,A.E.,et al, 1997
Clinical Utility of Diffusion-Weighted Magnetic Resonance Imaging in the Assessment of Ischemic Stroke
Ann Neurol 41:574-580, 5651997., Letsep,H.L.,et al, 1997
Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997
New Variant Creutzfeldt-Jakob Disease:Neurological Features and Diagnostic Tests
Lancet 350:903-907, Zeidler,M.,et al, 1997
New Variant Creutzfeldt-Jakob Disease:Psychiatric Features
Lancet 350:908-910, Zeidler,M.,et al, 1997
Causes and Mechanisms of Cerebellar Infarction in Young Patients
Stroke 28:2400-2404, Barinagarrementeria,F.,et al, 1997
Spinocerebellar Ataxia Type 6, Molecular & Clin Features of 35 Japanese Pts (1 Homozygous for CAG Repeat Expan)
Neurol 49:1238-1243, 11961997., Matsumura,R.,et al, 1997